• Under the skin: tattoos and their consequences

    Tattoos are becoming increasingly popular, but these permanent body ornaments can cause considerable damage to the skin.

  • Proton-pump inhibitors and cancer therapy: a bad combination?

    Some retrospective studies suggested that combination of PPIs with immuno-chemotherapies, is associated with worse outcomes. What's new on this issue?

  • Medical Case: A patient with upper abdominal pain, nausea and fainting

    A 47-year-old female patient complains of an episode of fainting and unwanted weight loss, in addition to gastrointestinal issues. Could you guess a diagnosis?

  • When painful muscle cramps occur during sport: how to treat them?

    Athletes often treat cramps themselves, but the effectiveness of untargeted therapy is questionable. What helps with painful attacks and what doesn't?

  • How periodontal disease contributes to inflammation and rheumatoid arthritis

    Periodontal diseases enable oral mucosa tears, where citrullinated bacteria enter the bloodstream, leading to inflammatory immune cells and ACPA antibodies.

  • Options for augmentation in treatment-resistant age-related depression

    A substantial proportion geriatric patients taking antidepressants do not respond to therapy. Should they switch completely, just augment, and how?

  • A day at the ER: How many diagnoses can AI correctly make?

    ChatGPT could solve many questions on a medical exam, but using it on real people would quickly prove fatal, says a doctor who has put it to the test.

  • NET: What gastroenterologists should know

    Even gastroenterologists may struggle with this very special and heterogeneous group of neoplasms. But a correct diagnosis is usually within their grasp.

  • Psychedelics in psychiatry: yesterday, today, and tomorrow?

    In psychiatric therapy research, psychedelic-assisted psychotherapy is currently one of the most exciting areas of research. What trends could await us?

  • Psychedelic Augmented Psychotherapy: Science vs. Expectation

    Some patients seek psychedelic-augmented psychotherapy with quite high expectations. How should therapists approach this?

  • Obesity: can a healthy gut microbiome contribute to treatment?

    If the intestinal microbiome is unbalanced, chronic diseases or micro-inflammations often ensue. What role does intestinal flora dysfunction play in grade III obesity?

  • Medical Case: Patient with diarrhoea and lower abdominal pain

    A 20-year-old woman arrives to the emergency room with lower abdominal pain and changes in bowel movements. What is your probable diagnosis?

  • Dr Prateep Beed on psychedelics research, and its expanding contribution to medicine

    In this interview, Dr. Beed's global snapshot of today's psychedelics research covers therapeutics, policies, patient-doctor relations, and medical specialties.

  • Surgery for gastrointestinal tumours: Could AI take over soon?

    Artificial intelligence has also arrived in the operating room. Will it replace surgeons in the future?

  • Icons, gurus, and boundaries: Professional risks in psychedelic therapy settings

    Prof. Dr. Matthew Johnson looks at the challenges posed to psychedelics science professionals by patients' experiences and experimental settings.

  • Evidence-based psychedelic therapy: driven by science, away from bogus spiritual fixes

    Dr Henrik Jungaberle covers the INSIGHT 2023 themes, and the importance of scientific rigour in the expanding field of psychedelic therapy.

  • MDMA: a new hope for young people with PTSD

    Research is evaluating risks and suitability of MDMA assisted therapy for 15-17 year olds with PTSD. Ethically rigorous studies are needed to evaluate safety and efficacy.

  • Psilocybin: new therapeutic perspectives

    The two pilot studies, one on depression in Alzheimer's and one on Lyme disease, assess if psilocybin offers alternatives to ineffective standard treatments.

  • New ESC Guidelines 2023: An overview

    Five new guidelines were presented in the ESC Congress: acute coronary syndromes; heart failure; cardiomyopathies; cardio-vascular disease and diabetes; and endocarditis.

  • Interview: Psychedelic therapy in Italy, a long road ahead

    Where does Italy stand in psychedelic drug research? We discuss this with Dr Matteo Buonarroti, the first Italian doctor to complete the Mind Foundation's Augmented Psychotherapy Training.

  • 13 |
  • 14 |
  • 15 |
  • 16 |
  • 17 |
  • 18 |
  • 19 |
  • 20 |
  • 21 |
  • 22 |
  • 23 |